In the News
Publications & Media
May 06, 2020
Focal Pulsed Field Ablation for Pulmonary Vein Isolation and Linear Atrial Lesions: A Preclinical Assessment of Safety and Durability
"Point-by-Point Pulsed Field Ablation (+/- Radiofrequency Ablation) to Treat Atrial Fibrillation: A First-in-Human Trial" by Dr. Vivek Reddy
Each year, a few of the most impactful clinical trials are selected for the Heart Rhythm Society's Late-Breaking Clinical Trials sessions. Click to view Affera's system featured in the 2020 Late-Breaking Clinical Trials Session, Innovation Boulevard.
Join AFFERA
We are a highly selective team of talented individuals, whose aim is to have a major impact on developing a breakthrough, life-saving technology.
We believe in maximizing the unique talents of each individual, empowering everyone to contribute on multiple levels. If you are innovative, resourceful and hands-on, we want you on our team!
View our current openings below, or e-mail for more information.
Team
Doron Harlev
CEO, Founder
Doron is the founder and CEO of Affera, Inc. Prior to Affera, Doron co-founded and served as co-CEO at Rhythmia Medical, which developed a unique Electroanatomical Mapping System for the treatment of Cardiac Arrhythmia. Acquired by Boston Scientific in 2012, Rhythmia became Boston Scientific’s cardiac mapping and navigation division, where Doron served as Vice President of Product and Technology. Prior to Rhythmia, Doron held a variety of roles in an elite R&D unit in the Israeli Ministry of Defense.
Doron is a prolific inventor holding over 140 issued and pending patents. He is currently an advisor to a number of start-up companies, and serves as a Board member at Lexington Medical, Inc. Doron holds an MBA from MIT Sloan, M.Sc. EE from Tel Aviv University and B.Sc. EE from the Technion Israel Institute of Technology.
Leon Amariglio
Board Member
Leon currently serves as the CEO of Lexington Medical, Inc. Previously, Leon co-founded Rhythmia with Doron and served as Vice President at Boston Scientific upon Rhythmia’s acquisition.
Prior to Rhythmia, Leon led business development at Ceragon Networks Ltd, a wireless equipment provider, and worked at Deutsche Bank Alex. Brown leading financing and mergers and acquisition transactions. Leon holds an MBA degree from Harvard Business School and a Masters of Engineering degree from the University of Cambridge.
Phil Fleck
Board Member
Phil has been designing and building medical devices for most of his professional career. He has brought numerous products to market and uses that expertise at Norwich Ventures to assess new technologies and assist entrepreneurs with building their companies. Previously, he served on the board of Rhythmia Medical.
Prior to joining Norwich Ventures, Phil was the President and COO of Arrow International, with oversight of worldwide R&D and manufacturing. In addition, Phil oversaw opening the first-ever manufacturing plant in the Czech Republic by a U.S. company. Phil serves on the executive board of the Life Sciences Greenhouse of Central Pennsylvania. Phil graduated with a B.S. from Lehigh University and attended Harvard’s Advanced Management Program.
